CDH4 and digestive system neoplasm: In recent years, aberrant promoter methylation of CDH4 was detected in both gastrointestinal tumor and nasopharyngeal carcinoma, respectively [38–40], which demonstrated CDH4 methylation may be a common phenomenon in the process of tumorigenesis.